Exosomes and Extracellular Vesicles as Emerging Theranostic Platforms in Cancer Research
Open Access
- 30 November 2020
- Vol. 9 (12), 2569
- https://doi.org/10.3390/cells9122569
Abstract
Exosomes are endosome-derived nanovesicles produced by healthy as well as diseased cells. Their proteic, lipidic and nucleic acid composition is related to the cell of origin, and by vehiculating bioactive molecules they are involved in cell-to-cell signaling, both in healthy and pathologic conditions. Being nano-sized, non-toxic, biocompatible, scarcely immunogenic, and possessing targeting ability and organotropism, exosomes have been proposed as nanocarriers for their potential application in diagnosis and therapy. Among the different techniques exploited for exosome isolation, the sequential ultracentrifugation/ultrafiltration method seems to be the gold standard; alternatively, commercially available kits for exosome selective precipitation from cell culture media are frequently employed. To load a drug or a detectable agent into exosomes, endogenous or exogenous loading approaches have been developed, while surface engineering procedures, such as click chemistry, hydrophobic insertion and exosome display technology, allow for obtaining actively targeted exosomes. This review reports on diagnostic or theranostic platforms based on exosomes or exosome-mimetic vesicles, highlighting the diverse preparation, loading and surface modification methods applied, and the results achieved so far.This publication has 113 references indexed in Scilit:
- Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imagingBMC Medical Imaging, 2012
- Exosomes: New players in cell–cell communicationThe International Journal of Biochemistry & Cell Biology, 2012
- Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through METNature Medicine, 2012
- Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growthThe Journal of Experimental Medicine, 2012
- Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapyJournal of Cellular Physiology, 2011
- Exosome Secretion: Molecular Mechanisms and Roles in Immune ResponsesTraffic, 2011
- Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosuppressive function of mouse and human myeloid-derived suppressor cellsJCI Insight, 2010
- Microenvironmental pH Is a Key Factor for Exosome Traffic in Tumor CellsJournal of Biological Chemistry, 2009
- Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent mannerCancer Letters, 2009
- Shedding microvesicles: artefacts no moreTrends in Cell Biology, 2009